Maravai LifeSciences Inc...

NASDAQ: MRVI · Real-Time Price · USD
2.62
0.02 (0.77%)
At close: Aug 15, 2025, 3:59 PM
2.61
-0.19%
After-hours: Aug 15, 2025, 04:10 PM EDT

Maravai LifeSciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
259.19M 288.94M 883M 799.24M
Cost of Revenue
150.88M 148.74M 168.96M 140.56M
Gross Profit
108.31M 140.2M 714.04M 658.68M
Operating Income
-235.62M -31.65M 574.22M 554.64M
Interest Income
27.4M 27.73M 2.34M n/a
Pretax Income
-261.48M 617.74M 551.47M 530.76M
Net Income
-144.85M -119.03M 220.21M 182.04M
Selling & General & Admin
161.77M 151.39M 129.26M 100.06M
Research & Development
19.22M 17.28M 18.37M 15.22M
Other Expenses
162.93M 3.18M -7.8M -11.25M
Operating Expenses
343.93M 171.85M 139.83M 104.03M
Interest Expense
47.7M 45.89M 20.41M 30.26M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
494.8M 320.59M 308.79M 244.59M
Income Tax Expense
-1.86M 756.11M 60.81M 61.52M
Shares Outstanding (Basic)
137.91M 131.92M 131.54M 114.79M
Shares Outstanding (Diluted)
137.91M 131.92M 131.69M 121.97M
EPS (Basic)
-1.05 -0.9 1.67 1.59
EPS (Diluted)
-1.05 -0.9 1.67 1.56
EBITDA
-156.92M 712.41M 609.99M 585.78M
EBIT
-213.78M 663.63M 571.89M 561.02M
Depreciation & Amortization
56.87M 48.78M 38.1M 24.75M